These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 11389271)

  • 41. Comparison of the efficacy of three topical antiseptic solutions for the prevention of catheter colonization: a multicenter randomized controlled study.
    Yasuda H; Sanui M; Abe T; Shime N; Komuro T; Hatakeyama J; Matsukubo S; Kawano S; Yamamoto H; Andoh K; Seo R; Inoue K; Noda E; Saito N; Nogami S; Okamoto K; Fuke R; Gushima Y; Kobayashi A; Takebayashi T; Lefor AK;
    Crit Care; 2017 Dec; 21(1):320. PubMed ID: 29268759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness analysis of chlorhexidine gluconate compared with povidone-iodine solution for catheter-site care in Siriraj Hospital, Thailand.
    Maenthaisong R; Chaiyakunapruk N; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S94-101. PubMed ID: 17718250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters.
    Dünser MW; Mayr AJ; Hinterberger G; Flörl CL; Ulmer H; Schmid S; Friesenecker B; Lorenz I; Hasibeder WR
    Anesth Analg; 2005 Dec; 101(6):1778-1784. PubMed ID: 16301258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maintenance antisepsis in reducing the rate of late-onset central venous catheter-related bloodstream infection: A comparison of 0.05% and 1% chlorhexidine.
    Kikuchi M; Sato T; Okada S; Abe N; Sato A; Suzuki Y
    J Infect Chemother; 2020 Feb; 26(2):188-193. PubMed ID: 31495567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
    Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
    JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care.
    Mimoz O; Villeminey S; Ragot S; Dahyot-Fizelier C; Laksiri L; Petitpas F; Debaene B
    Arch Intern Med; 2007 Oct; 167(19):2066-72. PubMed ID: 17954800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis.
    Chaiyakunapruk N; Veenstra DL; Lipsky BA; Saint S
    Ann Intern Med; 2002 Jun; 136(11):792-801. PubMed ID: 12044127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial.
    Guenezan J; Marjanovic N; Drugeon B; Neill RO; Liuu E; Roblot F; Palazzo P; Bironneau V; Prevost F; Paul J; Pichon M; Boisson M; Frasca D; Mimoz O;
    Lancet Infect Dis; 2021 Jul; 21(7):1038-1048. PubMed ID: 33539734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care.
    Khare MD; Bukhari SS; Swann A; Spiers P; McLaren I; Myers J
    J Infect; 2007 Feb; 54(2):146-50. PubMed ID: 16678904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
    Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
    Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.
    León C; Ruiz-Santana S; Rello J; de la Torre MV; Vallés J; Alvarez-Lerma F; Sierra R; Saavedra P; Alvarez-Salgado F;
    Intensive Care Med; 2004 Oct; 30(10):1891-9. PubMed ID: 15278273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
    Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
    J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of chlorhexidine impregnated dressing and standard dressing for the prevention of central-line associated blood stream infection and colonization in critically ill pediatric patients: A randomized controlled trial.
    Duyu M; Karakaya Z; Yazici P; Yavuz S; Yersel NM; Tascilar MO; Firat N; Bozkurt O; Caglar Mocan Y
    Pediatr Int; 2022 Jan; 64(1):e15011. PubMed ID: 34610185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting zero catheter-related bloodstream infections in pediatric intensive care unit: a retrospective matched case-control study.
    Biasucci DG; Pittiruti M; Taddei A; Picconi E; Pizza A; Celentano D; Piastra M; Scoppettuolo G; Conti G
    J Vasc Access; 2018 Mar; 19(2):119-124. PubMed ID: 29148002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
    Timsit JF; Mimoz O; Mourvillier B; Souweine B; Garrouste-Orgeas M; Alfandari S; Plantefeve G; Bronchard R; Troche G; Gauzit R; Antona M; Canet E; Bohe J; Lepape A; Vesin A; Arrault X; Schwebel C; Adrie C; Zahar JR; Ruckly S; Tournegros C; Lucet JC
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1272-8. PubMed ID: 23043083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early prophylaxis of central venous catheter-related thrombosis using 1% chlorhexidine gluconate and chlorhexidine-gel-impregnated dressings: a retrospective cohort study.
    Yamashita T; Takamori A; Nakagawachi A; Tanigawa Y; Hamada Y; Aoki Y; Sakaguchi Y
    Sci Rep; 2020 Sep; 10(1):15952. PubMed ID: 32994455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.